Public health impact of adverse bone effects of oral corticosteroids.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 2014495)

Published in Br J Clin Pharmacol on June 01, 2001

Authors

T P van Staa1, L Abenhaim, C Cooper, B Zhang, H G Leufkens

Author Affiliations

1: Department of Pharmacoepidemiology and Pharmacotherapy, University of Utrecht, Sorbonnelaan 16, Utrecht, The Netherlands.

Articles citing this

Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ (2009) 2.90

Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43

Fractures of the proximal femur: correlates of radiological evidence of osteoporosis. Skeletal Radiol (2006) 1.43

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36

Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut (2004) 1.17

Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int (2011) 1.00

Disease risk score as a confounder summary method: systematic review and recommendations. Pharmacoepidemiol Drug Saf (2012) 0.85

Long-term therapy in COPD: any evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis (2009) 0.83

Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures. Clin Rheumatol (2006) 0.78

Access to bone densitometry increases general practitioners' prescribing for osteoporosis in steroid treated patients. Ann Rheum Dis (2004) 0.77

Survey of short-term oral corticosteroid administration by orthopaedic physicians in college and high school athletes. J Sports Sci Med (2009) 0.75

Relation between the development of osteoporosis and osteonecrosis following glucocorticoid in a rabbit model. Indian J Orthop (2016) 0.75

Schistosoma mansoni Tegument (Smteg) Induces IL-10 and Modulates Experimental Airway Inflammation. PLoS One (2016) 0.75

Rheumatoid arthritis patients with hip fracture: a nationwide study. Osteoporos Int (2014) 0.75

Articles cited by this

Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ (1991) 17.91

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med (1995) 13.01

The UK General Practice Research Database. Lancet (1997) 10.62

Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med (1991) 5.83

Accuracy of diagnosis of psychosis on general practice computer system. BMJ (1993) 4.88

Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75

Stratification by a multivariate confounder score. Am J Epidemiol (1976) 4.58

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med (1998) 4.38

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med (1997) 4.18

Public health methods--attributable risk as a link between causality and public health action. Am J Public Health (1995) 3.41

Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med (1983) 3.17

Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med (1994) 2.89

Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85

A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42

The VAMP Research multi-purpose database in the U.K. J Clin Epidemiol (1995) 2.37

Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis (1995) 2.10

Use of oral corticosteroids in the United Kingdom. QJM (2000) 1.95

The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf (2000) 1.70

Some insights into Miettinen's multivariate confounder score approach to case-control study analysis. Epidemiol Community Health (1979) 1.62

Epidemiology of osteoporosis. Bone (1992) 1.38

Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum (1985) 1.34

Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group. J Clin Endocrinol Metab (1998) 1.11

Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. J Rheumatol (1994) 0.91

On Miettinen's multivariate confounder score. J Clin Epidemiol (1998) 0.86

Definitions of attributable risk--revisited. Public Health Rev (1995) 0.82

Articles by these authors

Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet (2005) 8.49

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44

Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 6.33

Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17

Epidemiology of fractures in England and Wales. Bone (2001) 5.76

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64

Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science (2001) 5.40

European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet (1995) 5.02

Perspective. How many women have osteoporosis? J Bone Miner Res (1992) 4.99

Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet (2006) 4.95

European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88

Radiographic patterns of osteoarthritis of the knee joint in the community: the importance of the patellofemoral joint. Ann Rheum Dis (1992) 4.79

Use of oral corticosteroids and risk of fractures. J Bone Miner Res (2000) 4.75

A three-hybrid system to detect RNA-protein interactions in vivo. Proc Natl Acad Sci U S A (1996) 4.44

EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2000) 4.37

Bone density screening for osteoporosis. Lancet (1990) 3.87

Defining osteoarthritis of the hip for epidemiologic studies. Am J Epidemiol (1990) 3.77

Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int (2009) 3.74

Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos (2013) 3.64

A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int (2012) 3.62

Cohort profile: the Hertfordshire cohort study. Int J Epidemiol (2005) 3.62

Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron (1999) 3.49

Bone densitometry in clinical practice. BMJ (1995) 3.48

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int (2002) 3.45

Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res (1998) 3.44

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int (2010) 3.36

Venous thromboembolism among new users of different oral contraceptives. Lancet (1999) 3.25

The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res (1996) 3.25

Determinants of disability in osteoarthritis of the knee. Ann Rheum Dis (1993) 3.16

Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16

Fluoride in drinking water and risk of hip fracture in the UK: a case-control study. Lancet (2000) 3.16

Knee pain and disability in the community. Br J Rheumatol (1992) 3.15

Pectin esterification is spatially regulated both within cell walls and between developing tissues of root apices. Planta (1990) 3.03

GP job satisfaction in 1987, 1990 and 1998: lessons for the future? Fam Pract (2000) 2.99

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum (2003) 2.94

Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr (2007) 2.94

Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis. Osteoporos Int (2012) 2.81

Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) (2007) 2.81

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int (1997) 2.80

The Quebec Back Pain Disability Scale. Measurement properties. Spine (Phila Pa 1976) (1995) 2.75

Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med (1999) 2.74

Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas (2009) 2.74

Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years. BMJ (2000) 2.73

Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70

A global representation of vitamin D status in healthy populations. Arch Osteoporos (2012) 2.69

Osteoarthritis of the hip: an occupational disease in farmers. BMJ (1992) 2.69

Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res (2000) 2.55

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55

Occupational physical activities and osteoarthritis of the knee. Arthritis Rheum (2000) 2.54

Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res (2001) 2.50

Manual handling activities and risk of low back pain in nurses. Occup Environ Med (1995) 2.48

Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48

Use of statins and risk of fractures. JAMA (2001) 2.47

Prospective cohort study of predictors of incident low back pain in nurses. BMJ (1997) 2.46

Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43

A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42

Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39

Trends in admissions for hip fracture in England and Wales, 1968-85. BMJ (1990) 2.35

Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord (2001) 2.30

A population-based, randomized clinical trial on back pain management. Spine (Phila Pa 1976) (1997) 2.30

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum (2006) 2.28

How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum (2008) 2.27

Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology (2012) 2.25

Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24

Dietary calcium, physical activity, and risk of hip fracture: a prospective study. BMJ (1989) 2.24

Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24

A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study. Rheumatology (Oxford) (2005) 2.23

Acetabular dysplasia and hip osteoarthritis in Britain and Japan. Br J Rheumatol (1998) 2.22

Bacterial arthritis in an English health district: a 10 year review. Ann Rheum Dis (1986) 2.21

Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20

Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med (2008) 2.19

Broadband observations of the naked-eye gamma-ray burst GRB 080319B. Nature (2008) 2.16

Vitamin D and skeletal health in infancy and childhood. Osteoporos Int (2014) 2.16

Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Ann Pharmacother (2001) 2.14

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) (2000) 2.13

Relativistic jet activity from the tidal disruption of a star by a massive black hole. Nature (2011) 2.12

The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database. Rheumatology (Oxford) (2005) 2.11

Physical activity at 36 years: patterns and childhood predictors in a longitudinal study. J Epidemiol Community Health (1992) 2.11

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes. Diabetes Obes Metab (2006) 2.05

Fold and function predictions for Mycoplasma genitalium proteins. Fold Des (1998) 2.02

Severe diffuse non-scarring hair loss in systemic lupus erythematosus - clinical and histopathological analysis of four cases. J Eur Acad Dermatol Venereol (2011) 1.99

Use of oral corticosteroids in the United Kingdom. QJM (2000) 1.95

Are rates of ageing determined in utero? Age Ageing (1998) 1.95

Will elderly rest home residents wear hip protectors? Age Ageing (1998) 1.95

Muscle strength, activity, housing and the risk of falls in elderly people. Age Ageing (1989) 1.94

Diffusion tensor imaging and cognitive function in older adults with no dementia. Neurology (2011) 1.89

Risk factors for the development of low back pain in adolescence. Am J Epidemiol (2001) 1.89